Research
Sleep apnea, a sleep disorder marked by repeated interruptions in breathing during sleep, poses significant health risks if left untreated. Obstructive Sleep Apnea (OSA), the most common form, affects an estimated 936 million adults globally, with a notable prevalence among...
Continue reading
Chelsie Rohrscheib, Ph.D. Neuroscientist and Head Sleep Expert, WesperJanuary 31, 2024Atrial fibrillation (AFib), a prevalent cardiac arrhythmia affecting millions worldwide, frequently coexists with comorbidities such as obesity and obstructive sleep apnea (OSA). The intricate relationship between AFib and OSA underscores...
Continue reading
Central sleep apnea (CSA) is a sleep disorder characterized by intermittent pauses in breathing due to a failure of the brain's respiratory control centers. Unlike obstructive sleep apnea (OSA), where the pauses are caused by physical blockages in the airway,...
Continue reading
A new wave of weight loss medications like Ozempic is changing the game for people struggling with obesity. These drugs, belonging to a class called GLP-1 receptor agonists, not only promote weight loss but also offer additional health benefits. By...
Continue reading
In the realm of sleep medicine, the efficacy of treatment modalities for obstructive sleep apnea (OSA) remains a crucial consideration, particularly when symptoms persist despite intervention. This case study presents the journey of a middle-aged man diagnosed with moderate OSA,...
Continue reading